Search

everythinglearnresearchcommunity

for

Search:↓

Mutations in certain receptors can cause diseases and offer new treatment options.

The Hedgehog Signaling Pathway is important for skin and hair development and skin cancer treatment, but more research is needed to understand it fully.

17β-estradiol can reduce inflammation in the skin.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

People with premature hair graying have an imbalance between harmful and protective molecules in their body, hinting that antioxidants might help.

The document concludes that personalized treatment plans for hair loss in Asian men are necessary and more research is needed to develop effective guidelines.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Early surgical intervention and a multidisciplinary approach are crucial for managing complex cardio-obstetric patients.

The new bariatric surgery SAGI PGP is effective for weight loss and diabetes control with few complications.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Whale genes show changes that help them live in water, like less hair and better flippers.

Tiger cubs fed artificial milk lacking certain amino acids developed eye problems and hair loss.

Hair loss greatly affects quality of life, and dermatologists are crucial for proper diagnosis and treatment.

Thyroid function may influence hair loss after COVID-19.

Narrowband UVB treatment increases certain gene expressions in psoriasis skin and improves symptoms.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

A wearable device using electric stimulation can significantly improve hair growth.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

LL-37 helps stem cells grow and move, aiding tissue regeneration and hair growth.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

Cyclosporin extends hair growth in mice, but high-dose corticosteroids block this effect.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Early diagnosis of Trichorhinophalangeal syndrome type 1 is crucial for treatment and was achieved through clinical examination and family history.

Drosha and Dicer are essential for hair follicle health and preventing DNA damage in skin cells.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Understanding the genetics of rare inherited ichthyosis syndromes is key for better treatments and genetic counseling.